VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q38546284 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235921.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q38546284‏
024 ‎‡a 0000-0001-7065-2432‏ ‎‡2 orcid‏
024 ‎‡a 56666865700‏ ‎‡2 scopus‏
024 ‎‡a 57208415076‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q38546284‏
100 0 ‎‡a Federico Ferrari‏ ‎‡c Italian gynaecologist and academic researcher‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Federico Ferrari‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
400 0 ‎‡a Federico Ferrari‏ ‎‡c Italienischer forschender Gynäkologe‏ ‎‡9 de‏
670 ‎‡a Author's Adnexal torsion with normal ovary in the third trimester of a twin pregnancy: Case report and literature review‏
670 ‎‡a Author's Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy‏
670 ‎‡a Author's Comparison of survival outcome of patients with primary peritoneal and fallopian tube carcinoma treated with neoadjuvant chemotherapy versus primary debulking surgery.‏
670 ‎‡a Author's Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis‏
670 ‎‡a Author's Endometrial Carcinomas with Intestinal-Type Metaplasia/Differentiation: Does Mismatch Repair System Defects Matter? Case Report and Systematic Review of the Literature‏
670 ‎‡a Author's Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer‏
670 ‎‡a Author's Halogenated and organophosphorus flame retardants in European aquaculture samples‏
670 ‎‡a Author's Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study‏
670 ‎‡a Author's Laparoscopic management of a large urethral leiomyoma‏
670 ‎‡a Author's Latest developments and techniques in gynaecological oncology surgery‏
670 ‎‡a Author's Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival‏
670 ‎‡a Author's Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.‏
670 ‎‡a Author's Occurrence of halogenated flame retardants in commercial seafood species available in European markets‏
670 ‎‡a Author's Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery‏
670 ‎‡a Author's Polymerase ε‏
670 ‎‡a Author's Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.‏
670 ‎‡a Author's Porta hepatis peritonectomy and hepato-celiac lymphadenectomy in patients with stage IIIC-IV ovarian cancer: Diagnostic pathway, surgical technique and outcomes‏
670 ‎‡a Author's Prognostic factors in early-stage ovarian cancer‏
670 ‎‡a Author's Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma‏
670 ‎‡a Author's Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity‏
670 ‎‡a Author's Uterine rupture in pregnancy after hysteroscopic septum resection: a 20-year retrospective analysis‏
670 ‎‡a Author's Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study‏
909 ‎‡a (scopus) 57208415076‏ ‎‡9 1‏
909 ‎‡a (scopus) 56666865700‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000170652432‏ ‎‡9 1‏
919 ‎‡a validationofanenhancedrecoveryaftersurgeryprotocolingynecologicalsurgeryanitalianrandomizedstudy‏ ‎‡A Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study‏ ‎‡9 1‏
919 ‎‡a uterineruptureinpregnancyafterhysteroscopicseptumresectiona20yearretrospectiveanalysis‏ ‎‡A Uterine rupture in pregnancy after hysteroscopic septum resection: a 20-year retrospective analysis‏ ‎‡9 1‏
919 ‎‡a prognosticfactorsinearlystageovariancancer‏ ‎‡A Prognostic factors in early-stage ovarian cancer‏ ‎‡9 1‏
919 ‎‡a portahepatisperitonectomyandhepatoceliaclymphadenectomyinpatientswithstageiiic4ovariancancerdiagnosticpathwaysurgicaltechniqueandoutcomes‏ ‎‡A Porta hepatis peritonectomy and hepato-celiac lymphadenectomy in patients with stage IIIC-IV ovarian cancer: Diagnostic pathway, surgical technique and outcomes‏ ‎‡9 1‏
919 ‎‡a polymeraseεpoleultramutationinuterinetumorscorrelateswithtlymphocyteinfiltrationandincreasedresistancetoplatinumbasedchemotherapyinvitro‏ ‎‡A Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.‏ ‎‡9 1‏
919 ‎‡a polymeraseε‏ ‎‡A Polymerase ε‏ ‎‡9 1‏
919 ‎‡a opportunisticsalpingectomyduringpostpartumcontraceptionproceduresatelectiveandunscheduledcesareandelivery‏ ‎‡A Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery‏ ‎‡9 1‏
919 ‎‡a occurrenceofhalogenatedflameretardantsincommercialseafoodspeciesavailableineuropeanmarkets‏ ‎‡A Occurrence of halogenated flame retardants in commercial seafood species available in European markets‏ ‎‡9 1‏
919 ‎‡a neoadjuvantchemotherapydoesnotincreasetherateofcompleteresectionanddoesnotsignificantlyreducethemorbidityofvisceralperitonealdebulkingvpdinpatientswithstageiiic4ovariancancer‏ ‎‡A Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.‏ ‎‡9 1‏
919 ‎‡a multivariateanalysisofprognosticfactorsinprimarysquamouscellvulvarcancertheroleofperineuralinvasioninrecurrenceandsurvival‏ ‎‡A Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival‏ ‎‡9 1‏
919 ‎‡a latestdevelopmentsandtechniquesingynaecologicaloncologysurgery‏ ‎‡A Latest developments and techniques in gynaecological oncology surgery‏ ‎‡9 1‏
919 ‎‡a laparoscopicmanagementofalargeurethralleiomyoma‏ ‎‡A Laparoscopic management of a large urethral leiomyoma‏ ‎‡9 1‏
919 ‎‡a istherearoleforpostoperativetreatmentinpatientswithstageib2iibcervicalcancertreatedwithneoadjuvantchemotherapyandradicalsurgeryanitalianmulticenterretrospectivestudy‏ ‎‡A Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study‏ ‎‡9 1‏
919 ‎‡a halogenatedandorganophosphorusflameretardantsineuropeanaquaculturesamples‏ ‎‡A Halogenated and organophosphorus flame retardants in European aquaculture samples‏ ‎‡9 1‏
919 ‎‡a feasibilityoflaparoscopicdiaphragmaticperitonectomyduringvisceralperitonealdebulkingvpdinpatientswithstageiiic4ovariancancer‏ ‎‡A Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer‏ ‎‡9 1‏
919 ‎‡a endometrialcarcinomaswithintestinaltypemetaplasiadifferentiationdoesmismatchrepairsystemdefectsmattercasereportandsystematicreviewoftheliterature‏ ‎‡A Endometrial Carcinomas with Intestinal-Type Metaplasia/Differentiation: Does Mismatch Repair System Defects Matter? Case Report and Systematic Review of the Literature‏ ‎‡9 1‏
919 ‎‡a diaphragmaticperitonectomyvsfullthicknessresectionwithpleurectomyduringvisceralperitonealdebulkingvpdin100consecutivepatientswithstageiiic4ovariancancerasurgicalhistologicalanalysis‏ ‎‡A Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis‏ ‎‡9 1‏
919 ‎‡a comparisonofsurvivaloutcomeofpatientswithprimaryperitonealandfallopiantubecarcinomatreatedwithneoadjuvantchemotherapyversusprimarydebulkingsurgery‏ ‎‡A Comparison of survival outcome of patients with primary peritoneal and fallopian tube carcinoma treated with neoadjuvant chemotherapy versus primary debulking surgery.‏ ‎‡9 1‏
919 ‎‡a analysisoffailuresandclinicaloutcomeofadvancedepithelialovariancancerinpatientswithmicroscopicresidualdiseaseat2lookreassessmentfollowingprimarycytoreductivesurgeryand1lineplatinumbasedchemotherapy‏ ‎‡A Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy‏ ‎‡9 1‏
919 ‎‡a adnexaltorsionwithnormalovaryinthe3trimesterofatwinpregnancycasereportandliteraturereview‏ ‎‡A Adnexal torsion with normal ovary in the third trimester of a twin pregnancy: Case report and literature review‏ ‎‡9 1‏
919 ‎‡a tozziclassificationofdiaphragmaticsurgeryinpatientswithstageiiic4ovariancancerbasedonsurgicalfindingsandcomplexity‏ ‎‡A Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity‏ ‎‡9 1‏
919 ‎‡a survivalimplicationoflymphadenectomyinpatientssurgicallytreatedforapparentearlystageuterineserouscarcinoma‏ ‎‡A Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BAV|495_391975
996 ‎‡2 NUKAT|n 2005114423
996 ‎‡2 LC|no2007068004
996 ‎‡2 ICCU|LO1V390218
996 ‎‡2 JPG|500015299
996 ‎‡2 ICCU|CUBV168626
996 ‎‡2 LC|n 87882088
996 ‎‡2 DNB|101634144X
996 ‎‡2 NKC|jo2016928070
996 ‎‡2 DNB|133691365
996 ‎‡2 PLWABN|9810584808305606
996 ‎‡2 ISNI|000000038659629X
996 ‎‡2 ISNI|0000000512273265
996 ‎‡2 ISNI|0000000051153198
996 ‎‡2 RERO|A019103396
996 ‎‡2 CAOONL|ncf11906273
996 ‎‡2 SUDOC|07047642X
996 ‎‡2 DNB|1269125613
996 ‎‡2 ISNI|0000000109636628
996 ‎‡2 LC|no2022126369
996 ‎‡2 DNB|111657697X
996 ‎‡2 BNF|17781805
996 ‎‡2 LC|no2003052177
996 ‎‡2 BNF|17026586
996 ‎‡2 J9U|987007461691005171
996 ‎‡2 BIBSYS|13020092
996 ‎‡2 DNB|127523707
996 ‎‡2 BNF|16666025
996 ‎‡2 PTBNP|1904941
996 ‎‡2 NII|DA1640045X
996 ‎‡2 DE633|pe30031116
996 ‎‡2 RERO|A008762371
996 ‎‡2 DNB|141735309
996 ‎‡2 ISNI|0000000402008989
996 ‎‡2 PLWABN|9813136341905606
996 ‎‡2 BNF|13618250
996 ‎‡2 LC|n 2013069706
996 ‎‡2 DNB|1269120832
996 ‎‡2 NDL|01148658
996 ‎‡2 NSK|000662693
996 ‎‡2 ISNI|0000000019510343
996 ‎‡2 DNB|122537645
996 ‎‡2 PTBNP|1473993
996 ‎‡2 DNB|1045682756
996 ‎‡2 ICCU|CFIV266182
996 ‎‡2 SZ|133691365
996 ‎‡2 PLWABN|9810661757305606
996 ‎‡2 SZ|1045682756
996 ‎‡2 ISNI|000000003071518X
996 ‎‡2 DNB|1330643992
996 ‎‡2 CAOONL|ncf11399343
996 ‎‡2 ICCU|MILV179868
996 ‎‡2 LC|nb2016025806
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏